Susan Baigent

Title: Innovator Spotlight: Susan Baigent and Her Contributions to Marek's Disease Research

Introduction: Susan Baigent, located in Goring, Great Britain, is an accomplished inventor known for her significant contribution to veterinary medicine through her groundbreaking patent. With a focus on Marek's Disease Virus Serotype-1 (MDV-1), her innovative work has the potential to impact poultry health and vaccination strategies.

Latest Patents: Susan Baigent holds a patent for assay methods for MDV-1. This patent details a novel approach for quantifying both vaccine and virulent strains of Marek's Disease Virus in biological samples from birds. The method involves providing a biological sample, isolating nucleic acid, and utilizing real-time quantitative PCR (qPCR) to amplify a specific region of the pp38 gene. It also includes the use of detectable nucleic acid probes to measure changes in signal, thereby allowing for the absolute quantification of the virus strains.

Career Highlights: Susan is part of Zoetis LLC, a leading animal health company dedicated to improving the health and productivity of animals. Her role allows her to apply her expertise in molecular biology and virology to develop solutions for veterinary challenges.

Collaborations: Throughout her career, Susan has collaborated with notable colleagues, including Venugopal Nair and Hervé Le Galludec. These partnerships highlight the collaborative nature of scientific research, emphasizing how teamwork can lead to innovative solutions in veterinary medicine.

Conclusion: Susan Baigent's contributions to the field of veterinary science, particularly her patent relating to Marek's Disease Virus, underscore her commitment to advancing animal health. Her innovative methods not only enhance our understanding of viral quantification but also pave the way for improved vaccination protocols that can benefit the poultry industry.